|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2008-4-23
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Anemia of chronic kidney disease (CKD) decreases patients' health-related quality of life (HRQoL). The objective of this subanalysis was to determine the effect of every-other-week (Q2W) darbepoetin alfa on hemoglobin (Hb) levels and HRQoL measures in subjects with CKD who are naïve to erythropoiesis-stimulating agents (ESAs).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1473-4877
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
24
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1091-100
|
|
pubmed:meshHeading |
pubmed-meshheading:18328118-Aged,
pubmed-meshheading:18328118-Anemia,
pubmed-meshheading:18328118-Creatinine,
pubmed-meshheading:18328118-Erythropoietin,
pubmed-meshheading:18328118-Female,
pubmed-meshheading:18328118-Glomerular Filtration Rate,
pubmed-meshheading:18328118-Hematinics,
pubmed-meshheading:18328118-Hemoglobins,
pubmed-meshheading:18328118-Humans,
pubmed-meshheading:18328118-Kidney Failure, Chronic,
pubmed-meshheading:18328118-Male,
pubmed-meshheading:18328118-Quality of Life,
pubmed-meshheading:18328118-Renal Dialysis
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
The association of darbepoetin alfa with hemoglobin and health-related quality of life in patients with chronic kidney disease not receiving dialysis.
|
|
pubmed:affiliation |
Yale School of Medicine, New Haven, CT 06520-8029, USA. ali.abu-alfa@yale.edu <ali.abu-alfa@yale.edu>
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
